Future of Merck KGaA/Pfizer’s Bavencio at risk despite bladder trial success
Trending menu:
-
![]()
New clinical trial for use of cell-free DNA in managing colorectal cancer
-
![]()
Clinical trials landscape of checkpoint modulator trials
-
![]()
Gene silencing therapy’s fast-track approval to expand treatment options for Huntington’s patients
-
![eTMF Cancer Research]()
Exploring efficiencies from eTMF with Cancer Research UK
-
![Opdivo]()
Opdivo (Nivolumab) for the Treatment of Unresectable or Metastatic Melanoma
-
![]()
Nerlynx (neratinib) for the Treatment of Breast Cancer
Most Read
- Exploring efficiencies from eTMF with Cancer Research UK
- FDA accelerated review denial is a blow to Spectrum’s poziotinib
- New drugs and therapeutic options help the immune system fight cancer
- Roche’s Tecentriq threatens BMS’ Opdivo in small cell lung cancer market
- The challenges of using stem cells in neurology
Company A-Z
Latest Content
IQVIA unveils new global site network to increase trial opportunities
IQVIA, a life sciences technology solutions provider, has launched a technology-based global site network that opens opportunities for more clinical trials at experienced clinical and research sites.
Favilavir approved as experimental coronavirus drug
Zhejiang Hisun Pharmaceutical’s anti-viral drug Favilavir (Favipiravir) has been approved as an investigational therapy to treat the coronavirus, reported local media.
New clinical trial firm Curavit Clinical Research officially launches
A new clinical trials company, Curavit Clinical Research, has been launched to help realise the potential of decentralised clinical trials.
Laboratorios Planes’ Product Catalogue
Our best own brand product selection to the highest quality plant extracts.
UCL researchers test cough syrup drug for Parkinson’s
A research team at University College London has secured funding to evaluate the use of cough syrup drug ambroxol to treat Parkinson’s disease patients in clinical trials.
SOM Biotech: A Top Spanish Start-Up to Follow in 2020
SOM Biotech has made Sifted's list as one of the Top Spanish Start-ups to follow in 2020.
Partnership presentation
Uniquid advantages of SOMAI PRO include identification of new mechanisms of action of drugs (biological activity defined by Molecular Field Maps, which were not described before and non-structural analogues identification reliable patent protection.
January’s top news stories
A Phase I clinical trial of monoclonal antibody (mAb) CIS43LS against malaria started the enrolment of healthy adults at the NIH Clinical Center in Bethesda, Maryland, US, and Acceleron Pharma reported that the Phase II PULSAR study of sotatercept achieved its primary and major secondary endpoints for the treatment of pulmonary arterial hypertension (PAH). Clinicaltrialsarena.com wraps up key headlines from January 2020.
Ethical GmbH upgrades eAdjudication®
Ethical GmbH upgrades the study designer functionality available with the eAdjudication® software platform to allow customers to independently create and configure new studies in their company dedicated workspace.
Latest News
Close
Close
Close
Go Top